NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
9 hedge funds and large institutions have $500K invested in NeuroMetrix, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 5 closing their positions.
42% more capital invested
Capital invested by funds: $351K → $500K (+$149K)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
10% less funds holding
Funds holding: 10 → 9 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$95.4K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$91.5K |
| 3 |
BlackRock
New York
|
+$87.6K |
| 4 |
Renaissance Technologies
New York
|
+$19.4K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$19K |
| 2 |
Morgan Stanley
New York
|
-$11K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| 5 |
Barclays
London,
United Kingdom
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $187K | +$91.5K | +212 | +82% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $88K | +$95.4K | +221 | New |
|
|
3
BlackRock
New York
| $81K | +$87.6K | +203 | New |
|
|
4
Renaissance Technologies
New York
| $76K | +$19.4K | +45 | +31% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $20K | +$2.16K | +5 | +11% |
|
|
6
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $16K | +$17.7K | +41 | New |
|
7
Bank of New York Mellon
New York
| $12K | +$13.4K | +31 | New |
|
|
PAG
8
Private Advisor Group
Morristown,
New Jersey
| $12K | +$13.4K | +31 | New |
|
9
Northern Trust
Chicago,
Illinois
| $8K | +$8.63K | +20 | New |
|
|
10
Goldman Sachs
New York
| – | -$19K | -40 | Closed |
|
|
11
Morgan Stanley
New York
| – | -$11K | -23 | Closed |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$10K | -21 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$1K | -2 | Closed |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | -$1K | -1 | Closed |
|
NURO Hedge Fund Activity: Q1 2017 in Review
9 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2017, worth a combined $500K — up 42% from $351K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NURO positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $95.4K. The largest seller was Goldman Sachs, exiting entirely with an estimated $19K sold.
- 9 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2017, down from 10 in Q4 2016.
- Funds reported $500K of NeuroMetrix, Inc. Common Stock stock for Q1 2017, up 42% quarter-over-quarter.
- 6 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2017 and 5 closed out, a net change of +1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2017 was Virtu KCG Holdings, an estimated $95.4K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q1 2017 was Goldman Sachs, an estimated $19K sold.
Based on aggregated 13F filings for Q1 2017.